Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NDSN | DOV |
|---|---|---|
| Price | $328.34 | $187.80 |
| Change today | ▲ 0.15% | ▲ 0.40% |
| Market cap | $18.29B | $25.29B |
| Return, 3 months | +11.4% | -13.3% |
| Return, year to date | +37.8% | -3.1% |
| Return, 1 year | +45.4% | +14.0% |
| P/E (TTM) | 33.2 | 22.6 |
| P/B | 5.6 | 3.3 |
| P/E percentile vs own 5y | – | 78th |
| Dividend yield | 1.00% | 1.11% |
| Revenue growth (YoY, latest qtr) | – | +6.9% |
| Net profit growth (YoY) | – | +11.9% |
| Gross margin | – | 39.6% |
| Operating margin | – | 16.9% |
| Net margin | – | 13.5% |
| Return on equity | – | 15.0% |
| Analyst target vs. price | +10.9% | +32.0% |
| Analyst buy share | 75% | 80% |
| RSI (14) | 62 | 39 |
| 30-day volatility | 28.8% | 18.6% |
| Max drawdown, 1 year | -14.1% | -19.6% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
